Cancer Medicine

Breast Medical Oncology

20 Recent Publications

This is a list of the 20 publications most recently added to the Research Profiles database. This shows the publication activity that is ongoing at the institution.The source of publications for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  A.M. Gonzalez-Angulo; G.R. Blumenschein

  Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer

  Cancer Treatment Reviews. 2013;39(4):313-320.

• 2.

  2013

  Keila E. Torres; Vinod Ravi; Katherine Kin; Min Yi; B. Ashleigh Guadagnolo; Caitlin D. May; Banu K. Arun; Kelly K. Hunt; Ryan Lam; Guy Lahat; et al.

  Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer

  Annals of Surgical Oncology. 2013;20(4):1267-1274.

• 3.

  2013

  Leonel F. Hernandez-Aya; Ana M. Gonzalez-Angulo

  Adjuvant Systemic Therapies in Breast Cancer

  Surgical Clinics of North America. 2013;93(2):473-491.

• 4.

  2013

  Mohan Liu; James N. Ingle; Brooke L. Fridley; Aman U. Buzdar; Mark E. Robson; Michiaki Kubo; Liewei Wang; Anthony Batzler; Gregory D. Jenkins; Tracy L. Pietrzak; et al.

  TSPYl5 SNPs: Association with plasma estradiol concentrations and aromatase expression

  Molecular Endocrinology. 2013;27(4):657-670.

• 5.

  2013

  A.M. Gonzalez-Angulo; S. Liu; H. Chen; M. Chavez-MacGregor; A. Sahin; G.N. Hortobagyi; G.B. Mills; K.-A. Do; F. Meric-Bernstam

  Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy

  Annals of Oncology. 2013;24(4):909-916.

• 6.

  2013

  Stig E. Bojesen; Karen A. Pooley; Sharon E. Johnatty; Jonathan Beesley; Kyriaki Michailidou; Jonathan P. Tyrer; Stacey L. Edwards; Hilda A. Pickett; Howard C. Shen; Chanel E. Smart; et al.

  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

  Nature Genetics. 2013;45(4):371-384.

• 7.

  2013

  Antonio Giordano; Brian L. Egleston; David Hajage; Joseph Bland; Gabriel N. Hortobagyi; James M. Reuben; Jean-Yves Pierga; Massimo Cristofanilli; Francois-Clement Bidard

  Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients

  Clinical Cancer Research. 2013;19(6):1596-1602.

• 8.

  2013

  Vinita Takiar; Eric A. Strom; Donald P. Baumann; Funda Meric-Bernstam; Ricardo H. Alvarez; Ana M. Gonzalez-Angulo

  Locoregional interaction of ixabepilone (Ixempra) after breast cancer radiation

  Oncologist. 2013;18(3):265-270.

• 9.

  2013

  K Kai; T Iwamoto; T Kobayashi; Y Arima; Y Takamoto; N Ohnishi; C Bartholomeusz; R Horii; F Akiyama; G N Hortobagyi; et al.

  Ink4a/Arf^-/- and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f^- quiescent cells

  Oncogene. 2013.

• 10.

  2013

  Mariana Chavez-Macgregor; Ana Maria Gonzalez-Angulo

  Breast cancer in 2012: New drugs, new knowledge, new targets

  Nature Reviews Clinical Oncology. 2013;10(2):75-76.

• 11.

  2013

  Y. Delpech; C. Coutant; L. Hsu; E. Barranger; T. Iwamoto; C.H. Barcenas; G.N. Hortobagyi; R. Rouzier; F.J. Esteva; L. Pusztai

  Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas

  British Journal of Cancer. 2013;108(2):285-291.

• 12.

  2013

  Naoki Hayashi; Colleen M. Costelloe; Tsuyoshi Hamaoka; Caimiao Wei; Naoki Niikura; Richard L. Theriault; Gabriel N. Hortobagyi; John E. Madewell; Naoto T. Ueno

  A Prospective Study of Bone Tumor Response Assessment in Metastatic Breast Cancer

  Clinical Breast Cancer. 2013;13(1):24-30.

• 13.

  2013

  Elizabeth A. Mittendorf; Thomas A. Buchholz; Susan L. Tucker; Funda Meric-Bernstam; Henry M. Kuerer; Ana M. Gonzalez-Angulo; Isabelle Bedrosian; Gildy V. Babiera; Karen Hoffman; Min Yi; et al.

  Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy

  Annals of Surgery. 2013;257(2):173-179.

• 14.

  2013

  Vicente Valero

  Managing Ixabepilone Adverse Events with Dose Reduction

  Clinical Breast Cancer. 2013;13(1):1-6.

• 15.

  2013

  Heath D. Skinner; Eric A. Strom; Sabin B. Motwani; Wendy A. Woodward; Marjorie C. Green; Gildy Babiera; Daniel J. Booser; Funda Meric-Bernstam; Thomas A. Buchholz

  Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy

  Radiation Oncology. 2013;8(1).

• 16.

  2013

  Julie E. Lang; Welela Tereffe; Melissa P. Mitchell; Roshni Rao; Lei Feng; Funda Meric-Bernstam; Isabelle Bedrosian; Henry M. Kuerer; Kelly K. Hunt; Gabriel N. Hortobagyi; et al.

  Primary Tumor Extirpation in Breast Cancer Patients Who Present with Stage IV Disease is Associated with Improved Survival

  Annals of Surgical Oncology. 2013:1-7.

• 17.

  2013

  Gary R. Zirpoli; Patrick M. Brennan; Chi-Chen Hong; Susan E. McCann; Gregory Ciupak; Warren Davis; Joseph M. Unger; G. Thomas Budd; Dawn L. Hershman; Halle C.F. Moore; et al.

  Supplement use during an intergroup clinical trial for breast cancer (S0221)

  Breast Cancer Research and Treatment. 2013:1-11.

• 18.

  2013

  Funda Meric-Bernstam; Angelica M. Gutierrez-Barrera; Jennifer Litton; Lauren Mellor-Crummey; Kaylene Ready; Ana Maria Gonzalez-Angulo; Karen H. Lu; Gabriel N. Hortobagyi; Banu K. Arun

  Genotype in BRCA-associated breast cancers

  Breast Journal. 2013;19(1):87-91.

• 19.

  2013

  Scott D. Ramsey; William E. Barlow; Ana M. Gonzalez-Angulo; Sean Tunis; Laurence Baker; John Crowley; Patricia Deverka; David Veenstra; Gabriel N. Hortobagyi

  Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes

  Contemporary Clinical Trials. 2013;34(1):1-9.

• 20.

  2013

  Paul E Goss; Ian E Smith; Joyce O'Shaughnessy; Bent Ejlertsen; Manfred Kaufmann; Frances Boyle; Aman U Buzdar; Pierre Fumoleau; William Gradishar; Miguel Martin; et al.

  Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: A randomised, controlled, phase 3 trial

  The Lancet Oncology. 2013;14(1):88-96.